Abbotindia
Live Price
Recent news and updates for ABBOTINDIA will appear here soon.
"Caution advised for ABBOTINDIA investors. AI signals correlate with a sustained bearish trend. Technical indicators suggest further consolidation within the healthcare sector before a reliable long-term bottom is established."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, hypothyroidism, central nervous system, vaccines, and multispecialty, including insomnia, vertigo, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.
As of the latest market session, Abbotindia (ABBOTINDIA) is trading at ₹25,635, representing a move of -1.95% from the previous close.
Abbotindia is listed and traded under the ticker symbol ABBOTINDIA on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Abbotindia's stock price moved by -1.95%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 18% bullish probability for ABBOTINDIA stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Abbotindia shares reached a high of ₹30,655 and hit a low of ₹24,650.
ABBOTINDIA exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 8,621 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Abbotindia has a market capitalization of ₹54716.95 Cr, designating its size class inside the Healthcare sector.
Abbotindia has a current dividend yield of 205.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Abbotindia's trailing Price-to-Earnings (P/E) ratio is 33.89. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Abbotindia (ABBOTINDIA) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Abbotindia's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore ABBOTINDIA's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for ABBOTINDIA are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Abbotindia operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.